Angela J. James, PhD

Vice President, Head of Clinical Pharmacology
MacroGenics, Inc.

Dr. Angela James is Vice President, Head of Clinical Pharmacology, at MacroGenics Inc., and a member of ASCPT since 1995. She is currently a member of the Joint Steerinc Committee for the Oncology Community and the Special Programming Committee for the 2022 Annual Meeting. Prior to joining MacroGenics Inc., Dr. James held roles of increasing responsibility as the Global Clinical Pharmacology Lead at Astellas, Celgene and Alcon/Novartis. Prior to leaving Astellas, Dr. James transitioned to the role of Global Development Project Leader and led cross-functional project teams to successfully execute on global strategies for the development of novel immuno-oncology agents including an innovative cancer vaccine. Dr. James earned a B.A. in Biology from Rice University and a Ph.D. in Pharmaceutical Sciences with a research focus in Pharmacokinetic/Pharmacodynamic Modeling and Simulation from University of Maryland, Baltimore. She also earned a M.S. in Pharmacometrics from University of Maryland, Baltimore. Dr. James is passionate about utilizing her scientific acumen and leadership abilities to bring novel therapeutics to patients who urgently need safe and effective drugs.

Disclosure information not submitted.

Presentation(s):

• Networking Session Sponsored by Janssen

  Tuesday, January 11, 2022
  5:05 PM – 5:35 PM ET

• Oncology (ONC) Community

  Thursday, January 13, 2022
  3:00 PM – 4:00 PM ET

• Poster Walk: Maternal & Pediatric Therapeutic Optimization

  Wednesday, March 16, 2022
  5:30 PM – 6:00 PM ET

• Featured Speaker - Daren J. Austin, PhD

  Friday, March 18, 2022
  12:30 PM – 1:00 PM ET

• Small But Mighty: Innovative Clinical Trial Designs in Patient Populations of Limited Size - Day 1

  Thursday, May 12, 2022
  8:00 AM – 12:00 PM ET

• Small But Mighty: Innovative Clinical Trial Designs in Patient Populations of Limited Size - Day 2

  Friday, May 13, 2022
  8:00 AM – 12:00 PM ET